Search in:

Expert Opinion on Investigational Drugs Volume 14, 2005 - Issue 6

Submit an article Journal homepage

Views

CrossRef citations to date

Altmetric

Review

The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management

Octaviano A Roges The Whittier Institute for Diabetes, 9894 Genesee Avenue, La Jolla, CA 92037, USA. [email protected]

Marilyn Baron The Whittier Institute for Diabetes, 9894 Genesee Avenue, La Jolla, CA 92037, USA. [email protected]

Athena Philis-Tsimikas The Whittier Institute for Diabetes, 9894 Genesee Avenue, La Jolla, CA 92037, USA. [email protected]

Pages 705-727 | Published online: 11 Jul 2005

Cite this article
https://doi.org/10.1517/13543784.14.6.705

References
Citations
Metrics
Reprints & Permissions

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (14)

Figen Topyildiz, Sinem Kiyici, Zulfiye Gul, Deniz Sigirli, Metin Guclu, Gurcan Kisakol & Sinan Cavun. (2016) Exenatide Treatment Causes Suppression of Serum Ghrelin Levels following Mixed Meal Test in Obese Diabetic Women. Journal of Diabetes Research 2016, pages 1-7.
Crossref

Ying Hong, Jasper Dingemanse, Patricia Sidharta & Donald E. Mager. (2013) Population Pharmacodynamic Modeling of Hyperglycemic Clamp and Meal Tolerance Tests in Patients with Type 2 Diabetes Mellitus. The AAPS Journal 15:4, pages 1051-1063.
Crossref

Stephan Petersenn, Nicole Unger, Ke Hu, Brigitte Weisshaar, Yilong Zhang, Emmanuel Bouillaud, Karina Hermosillo Reséndiz, Yanfeng Wang & Klaus Mann. (2013) Pasireotide (SOM230), a Novel Multireceptor‐Targeted Somatostatin Analogue, Is Well Tolerated When Administered as a Continuous 7‐Day Subcutaneous Infusion in Healthy Male Volunteers. The Journal of Clinical Pharmacology 52:7, pages 1017-1027.
Crossref

Emma R. Parmee, Ranabir Sinharoy, Feng Xu, Jeffrey C. Givand & Lawrence A. Rosen. 2012. Case Studies in Modern Drug Discovery and Development. Case Studies in Modern Drug Discovery and Development 10 44 .

Roger S. Mazze, Ellie S. Strock, Richard M. Bergenstal, Amy Criego, Robert Cuddihy, Oded Langer, Gregg D. Simonson & Margaret A. Powers. 2011. Staged Diabetes Management. Staged Diabetes Management 77 137 .

Tasir S. Haque, Rogelio L. Martinez, Ving G. Lee, Douglas G. Riexinger, Ming Lei, Ming Feng, Barry Koplowitz, Claudio Mapelli, Christopher B. Cooper, Ge Zhang, Christine Huang, William R. Ewing & John Krupinski. (2010) Exploration of structure?activity relationships at the two C-terminal residues of potent 11mer Glucagon-Like Peptide-1 receptor agonist peptides via parallel synthesis. Peptides 31:7, pages 1353-1360.
Crossref

Tasir S. Haque, Ving G. Lee, Douglas Riexinger, Ming Lei, Sarah Malmstrom, Li Xin, Songping Han, Claudio Mapelli, Christopher B. Cooper, Ge Zhang, William R. Ewing & John Krupinski. (2010) Identification of potent 11mer Glucagon-Like Peptide-1 Receptor agonist peptides with novel C-terminal amino acids: Homohomophenylalanine analogs. Peptides 31:5, pages 950-955.
Crossref

Hanna E. Silber, Nicolas Frey & Mats O. Karlsson. (2013) An Integrated Glucose‐Insulin Model to Describe Oral Glucose Tolerance Test Data in Healthy Volunteers. The Journal of Clinical Pharmacology 50:3, pages 246-256.
Crossref

Petra M. Jauslin, Hanna E. Silber, Nicolas Frey, Ronald Gieschke, Ulrika S. H. Simonsson, Karin Jorga & Mats O. Karlsson. (2007) An Integrated Glucose-Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics. The Journal of Clinical Pharmacology 47:10, pages 1244-1255.
Crossref

Gábor Winkler. (2007) Incretin Enhancers, Incretinomimetics – from Therapeutic Concept to Clinical Application. Hungarian Medical Journal 1:2, pages 133-146.
Crossref

Irene Tom, Vivian Lee, Michael Dumas, Melanie Madanat, Jun Ouyang, Joanne Severs, John Andersen, Joane M. Buxton, James P. Whelan & Clark Q. Pan. (2007) Reproductible production of a PEGylated dual-acting peptide for diabetes. The AAPS Journal 9:2, pages E227-E234.
Crossref

Gábor Winkler. (2007) Incretin enhancers, incretin mimetics – from therapeutic concept to clinical application. Orvosi Hetilap 148:13, pages 579-587.
Crossref

Clark Q. Pan, Joanne M. Buxton, Stephanie L. Yung, Irene Tom, Ling Yang, Hongxing Chen, Margit MacDougall, Andrea Bell, Thomas H. Claus, Kevin B. Clairmont & James P. Whelan. (2006) Design of a Long Acting Peptide Functioning as Both a Glucagon-like Peptide-1 Receptor Agonist and a Glucagon Receptor Antagonist. Journal of Biological Chemistry 281:18, pages 12506-12515.
Crossref

Lauren R.H. Krumpe & Toshiyuki Mori. (2006) The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs. International Journal of Peptide Research and Therapeutics 12:1, pages 79-91.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management

Articles from other publishers (14)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management

Citations (14)

Articles from other publishers (14)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date